Corcept Therapeutics Inc (NASDAQ:CORT) showed up in the 13F filings of 377 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 12,151,276 | 89,064 | 0.74% | $489,817,956.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 12,062,212 | 14,382 | 0.12% | $419,764,959.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 9,494,822 | -42,249 | -0.44% | $330,419,806.00 |
| INGALLS & SNYDER LLC | 31 Mar, 2026 | 7,608,716 | 413,656 | 5.75% | $306,707.00 |
| INGALLS & SNYDER LLC | 31 Mar, 2026 | 7,195,060 | -502,924 | -6.53% | $250,388.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 5,758,528 | -330,819 | -5.43% | $200,396,774.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 5,682,783 | -75,745 | -1.32% | $229,072,983.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 4,820,568 | 4,820,568 | 0.00% | $194,317,096.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,077,196 | 4,077,196 | 0.00% | $164,351,771.00 |
| Parallel Advisors, LLC | 31 Mar, 2026 | 3,977,404 | 98,263 | 2.53% | $160,329,155.00 |
| Parallel Advisors, LLC | 31 Mar, 2026 | 3,879,141 | 7,689 | 0.20% | $134,994,107.00 |
| State Street Corp | 31 Mar, 2026 | 3,200,946 | 214,890 | 7.20% | $129,030,133.00 |
| FMR LLC | 31 Mar, 2026 | 3,190,192 | 775,552 | 32.12% | $128,596,647.00 |
| State Street Corp | 31 Mar, 2026 | 2,986,056 | 15,656 | 0.53% | $103,914,749.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,713,519 | 44,601 | 1.67% | $109,399,340.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,668,918 | 734,646 | 37.98% | $92,891,503.00 |
| FMR LLC | 31 Mar, 2026 | 2,414,640 | 212,702 | 9.66% | $84,029,460.00 |
| FIRST TRUST ADVISORS LP | 31 Mar, 2026 | 2,173,376 | 1,480,059 | 213.48% | $87,608,786.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 1,620,333 | -272,115 | -14.38% | $56,576,847.00 |
| Morgan Stanley | 31 Mar, 2026 | 1,592,059 | 405,081 | 34.13% | $55,403,726.00 |